REGIONAL VARIATION IN SEVERE ASTHMA PREVALENCE AND ORAL CORTICOSTEROID USE FOR PATIENTS IN AUSTRALIA: HEAT MAP ANALYSIS

被引：0
|
作者：
Wark, P. [1 ]
Hew, M. [2 ,3 ]
Xu, Y. [4 ]
Ghisla, C. [5 ]
Nguyen, T.
Erdemli, B. [6 ]
Samant, A.
Nan, C. [7 ]
机构：
[1] Univ Newcastle, Hunter Med Res Inst, Ctr Healthy Lungs, New Lambton Hts, Australia
[2] Monash Univ, Publ Hlth & Prevent Med, Melbourne, Vic, Australia
[3] Alfred Hosp, Melbourne, Vic, Australia
[4] AstraZeneca, Resp Inhaled, Cambridge, England
[5] AstraZeneca, Resp Inflammat & Autoimmun, Sydney, NSW, Australia
[6] ZS Associates, Zurich, Switzerland
[7] AstraZeneca, Med Evidence & Observat Res, Molndal, Sweden
来源：
RESPIROLOGY | 2021年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：84 / 84
页数：1
相关论文
共 50 条
  • [41] Short-term and Maintenance Oral Corticosteroid Use for German Patients with Asthma
    Schmidt, O.
    Nan, C.
    Lindner, R.
    Ilgin, Y.
    Schultz, T.
    Gylvin, L.
    Bleecker, E. R.
    PNEUMOLOGIE, 2020, 74 : S27 - S27
  • [42] Cost and health care utilization in patients with asthma and high oral corticosteroid use
    Broder, Michael S.
    Raimundo, Karina
    Ngai, Ka Ming
    Chang, Eunice
    Griffin, Noelle M.
    Heaney, Liam G.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2017, 118 (05) : 638 - 639
  • [43] Are We Poised to Change the Trajectory of Maintenance Oral Corticosteroid Use in Severe Asthma in the Age of Biologics?
    Lugogo, Njira
    Mohan, Arjun
    CHEST, 2022, 162 (01) : 4 - 5
  • [44] Cost-effectiveness analysis of dupilumab among patients with oral corticosteroid-dependent uncontrolled severe asthma in Japan
    Tohda, Yuji
    Matsumoto, Hisako
    Miyata, Masanori
    Taguchi, Yurie
    Ueyama, Maki
    Joulain, Florence
    Arakawa, Ichiro
    JOURNAL OF ASTHMA, 2022, 59 (11) : 2162 - 2173
  • [45] Clinical Remission in Oral Corticosteroid (OCS)-dependent Patients With Severe Asthma: An Analysis of the Andhi-IP and PONENTE Trials
    Menzies-Gow, A.
    Louis, R. E.
    Shavit, A.
    Price, D.
    Kwiatek, J.
    Cosio, B. G.
    Cohen, D.
    Keeling, N.
    Harrison, T.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [46] Eosinophilc Granulomatosis with Polyangiitis (EGPA) Prevalence and Oral Corticosteroid (OCS) Use Among Asthma Patients in a US Commercial Claims Database
    Gokhale, M.
    Bell, C.
    Doyle, S.
    Fairburn-Beech, J.
    Steinfeld, J.
    Van Dyke, M. K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [47] European Real-Life Experience Of Omalizumab (Xolair) And Maintenance Oral Corticosteroid Use In Patients With Severe Persistent Allergic Asthma
    Molimard, M.
    Niven, R.
    Buhl, R.
    Le Gros, V.
    Thielens, A.
    Thirl-well, J.
    Panahloo, Z.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2009, 123 (02) : S156 - S156
  • [48] Our experience of Dupilumab and maintenance oral corticosteroid use in severe adult atopic dermatitis associated to severe asthma.
    Omarjee, Bashir
    Krikorian, Bernard Gregoire
    Gros, Patrick
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [49] ORAL CORTICOSTEROID EXPOSURE IN PATIENTS WITH SEVERE EOSINOPHILIC ASTHMA: DATA FROM THE AUSTRALIAN MEPOLIZUMAB REGISTRY
    Thomas, D.
    Harvey, E.
    Stevens, S.
    McDonald, V
    Simpson, J.
    Upham, J.
    Katelaris, C.
    Harrington, J.
    Gibson, P.
    RESPIROLOGY, 2020, 25 : 124 - 124
  • [50] Oral Corticosteroid Reduction Between Biologics Initiated and Non-Initiated Patients with Severe Asthma
    Tanaka, Akihiko
    Takahashi, Mai
    Fukui, Ayako
    Arita, Yoshifumi
    Fujiwara, Masakazu
    Makita, Naoyuki
    Tashiro, Naoki
    JOURNAL OF ASTHMA AND ALLERGY, 2023, 16 : 839 - 849
12345